Reduced-dose whole-brain radiotherapy with tumor bed boost after upfront high-dose methotrexate for primary central nervous system lymphoma
Tae Hoon Lee, Joo Ho Lee, Ji Hyun Chang, Sung-Joon Ye, Tae Min Kim, Chul-Kee Park, Il Han Kim, Byoung Hyuck Kim, Chan Woo Wee
Radiat Oncol J. 2020;38(1):35-43.   Published online 2020 Mar 25     DOI:
Citations to this article as recorded by Crossref logo
The role of radiotherapy in newly diagnosed primary CNS lymphoma: A descriptive review and a pragmatic approach to clinical practice
Venkada Manickam Gurusamy, Saju Raveendran Divakar, Suparna Halsnad Chandramouli, Beena Kunheri, Hissa Hussain Al-Abdulla, Ghazia Shaikh, Rajiv Chaudary Apsani, Mohamed Riyaz Poolakundan, Palmira Caparrotti, Rabih Wafiq Hammoud, Noora Al-Hammadi
Clinical and Translational Radiation Oncology.2023; 39: 100559.     CrossRef
A necrotic primary central nervous system lymphoma in immunocompetent patient with MYC and BCL6 rearrangements (double-hit lymphoma): a case report
Nabil C N Khalil, Bashaer Imad Iwaiwi, Shurooq Hammad, Afnan W M Jobran, Saeed Itkaidek, Elias Edward Lahham
Oxford Medical Case Reports.2023;[Epub]     CrossRef
Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse
Paola Ghione, Katharine L. Lewis, Sabela Bobillo, Laksmi Nayak, Elisabeth Schorb, Lucia Nichelli, Andrea Ng, Kerry J. Savage, Pam McKay, Loretta Nastoupil, Carole Soussain, Kate Cwynarski
Hematological Oncology.2023;[Epub]     CrossRef
Primary lymphomas of the central nervous system
I.V. Cherkashina, M.A. Vernyuk, L.S. Khairullina, A.A. Fedenko
Onkologiya. Zhurnal imeni P.A.Gertsena.2023; 12(6): 82.     CrossRef
Advances in treatment of elderly primary central nervous system lymphoma
Nicolas Martinez‐Calle, Lisa K. Isbell, Kate Cwynarski, Elisabeth Schorb
British Journal of Haematology.2022; 196(3): 473.     CrossRef
Selective salvage radiotherapy could provide favorable outcomes in patients with refractory or relapsed primary central nervous system lymphoma
Nalee Kim, Do Hoon Lim, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim
Journal of Neuro-Oncology.2022; 156(2): 307.     CrossRef
Central Nervous System Lymphoma: Novel Therapies
Shannon P. Fortin Ensign, Diamone Gathers, Julia Erin Wiedmeier, Maciej M. Mrugala
Current Treatment Options in Oncology.2022; 23(1): 117.     CrossRef
Case series on patients with primary central nervous system lymphoma: From clinical presentations to outcomes
Kazem Anvari, James S. Welsh, Fatemeh Molaie
Clinical Case Reports.2022;[Epub]     CrossRef
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
Paul Lesueur, Gandhi Damaj, Khê Hoang-Xuan, Virginie Roland, Anna Schmitt, Olivier Chinot, Michel Fabbro, Philippe Agapé, Cécile Moluçon-Chabrot, Safia Chebrek, Agusti Alentorn, Loic Feuvret, Daniel Delgadillo, Dinu Stefan, Sylvain Choquet, Lucia Nichelli
Blood Advances.2022; 6(16): 4807.     CrossRef
Evidence-based expert consensus on the management of primary central nervous system lymphoma in China
Tong Chen, Yuanbo Liu, Yang Wang, Qing Chang, Jinsong Wu, Zhiliang Wang, Daoying Geng, Jin-Tai Yu, Yuan Li, Xiao-Qiu Li, Hong Chen, Dongxiao Zhuang, Jianyong Li, Bin Wang, Tao Jiang, Lanting Lyu, Yuqin Song, Xiaoguang Qiu, Wenbin Li, Song Lin, Xinghu Zhan
Journal of Hematology & Oncology.2022;[Epub]     CrossRef
Modern aspects of the diagnosis and treatment of primary central nervous system lymphomas
I.V. Cherkashina, M.A. Vernyuk, A.M. Chervontseva, E.E. Gushchina, L.S. Khairullina, A.A. Fedenko
Onkologiya. Zhurnal imeni P.A.Gertsena.2022; 11(6): 49.     CrossRef
Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
Clemens Seidel, Christine Viehweger, Rolf-Dieter Kortmann
Cancers.2021; 13(11): 2580.     CrossRef
Role of 23.4 Gy upfront whole-brain radiation therapy following high-dose methotrexate for primary central nervous system lymphoma: a comparative analysis of whole-brain radiation therapy versus no radiation therapy
Nalee Kim, Do Hoon Lim, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim
Journal of Neuro-Oncology.2021; 154(2): 207.     CrossRef
Faut-il moduler les contraintes de dose dans les organes à risque lors d’une irradiation en association avec un traitement anticancéreux systémique ?
E. Jouglar, J. Doyen, S. Supiot
Cancer/Radiothérapie.2020; 24(6-7): 594.     CrossRef